Alector 将来の成長
Future 基準チェック /26
Alector利益と収益がそれぞれ年間12.4%と31.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に-68.8% 22.2%なると予測されています。
主要情報
12.4%
収益成長率
22.2%
EPS成長率
| Biotechs 収益成長 | 28.4% |
| 収益成長率 | 31.3% |
| 将来の株主資本利益率 | -68.8% |
| アナリストカバレッジ | Good |
| 最終更新日 | 12 Nov 2024 |
今後の成長に関する最新情報
Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 11
Analysts Are Updating Their Alector, Inc. (NASDAQ:ALEC) Estimates After Its Full-Year Results
Mar 01Recent updates
Alector, Inc.'s (NASDAQ:ALEC) Business And Shares Still Trailing The Industry
Oct 24We Think Alector (NASDAQ:ALEC) Needs To Drive Business Growth Carefully
Sep 26Alector, Inc.'s (NASDAQ:ALEC) Price Is Right But Growth Is Lacking
Jul 11Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 11Analysts Are Updating Their Alector, Inc. (NASDAQ:ALEC) Estimates After Its Full-Year Results
Mar 01The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 27%
Jan 19Alector: Good Data, Huge Cash, No Near Term Catalyst
Jan 16Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Analysts Are Betting On Alector, Inc. (NASDAQ:ALEC) With A Big Upgrade This Week
Mar 02Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16Alector: Advancement Of Third Alzheimer's Drug Brings About Huge Potential
Oct 04AbbVie ends partnership with Alector for Alzheimer’s candidate
Jul 08Alector: Potential In Neurology And Cancer Treatments
Jun 14Need To Know: The Consensus Just Cut Its Alector, Inc. (NASDAQ:ALEC) Estimates For 2022
May 18Alector: Expect Phase 3 Data Next Year
Apr 16These Analysts Just Made An Downgrade To Their Alector, Inc. (NASDAQ:ALEC) EPS Forecasts
Feb 27Alector, Inc: A Newer Biotech Company With Big Potential
Jan 26業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 107 | -192 | -213 | -152 | 5 |
| 12/31/2025 | 128 | -113 | -134 | -33 | 9 |
| 12/31/2024 | 63 | -179 | -158 | -206 | 10 |
| 9/30/2024 | 62 | -158 | -222 | -221 | N/A |
| 6/30/2024 | 55 | -161 | -218 | -217 | N/A |
| 3/31/2024 | 96 | -121 | -199 | -197 | N/A |
| 12/31/2023 | 97 | -130 | -187 | -184 | N/A |
| 9/30/2023 | 96 | -141 | -190 | -187 | N/A |
| 6/30/2023 | 102 | -143 | -194 | -190 | N/A |
| 3/31/2023 | 126 | -135 | -208 | -204 | N/A |
| 12/31/2022 | 134 | -133 | -24 | -20 | N/A |
| 9/30/2022 | 133 | -136 | -25 | -21 | N/A |
| 6/30/2022 | 301 | 36 | 471 | 473 | N/A |
| 3/31/2022 | 227 | -29 | 483 | 486 | N/A |
| 12/31/2021 | 207 | -36 | 295 | 299 | N/A |
| 9/30/2021 | 198 | -33 | 297 | 300 | N/A |
| 6/30/2021 | 21 | -212 | -189 | -186 | N/A |
| 3/31/2021 | 18 | -202 | -190 | -187 | N/A |
| 12/31/2020 | 21 | -190 | -172 | -167 | N/A |
| 9/30/2020 | 22 | -169 | -154 | -148 | N/A |
| 6/30/2020 | 19 | -148 | -144 | -136 | N/A |
| 3/31/2020 | 23 | -127 | -125 | -108 | N/A |
| 12/31/2019 | 21 | -105 | -115 | -99 | N/A |
| 9/30/2019 | 24 | -92 | -102 | -88 | N/A |
| 6/30/2019 | 28 | -76 | -94 | -82 | N/A |
| 3/31/2019 | 28 | -62 | -84 | -81 | N/A |
| 12/31/2018 | 28 | -52 | 126 | 127 | N/A |
| 9/30/2018 | 22 | -45 | 141 | 143 | N/A |
| 6/30/2018 | 15 | -39 | N/A | 159 | N/A |
| 3/31/2018 | 8 | -35 | N/A | 171 | N/A |
| 12/31/2017 | 4 | -32 | N/A | -18 | N/A |
| 12/31/2016 | 0 | -15 | N/A | -13 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: ALEC今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: ALEC今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: ALEC今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: ALECの収益 ( 31.3% ) US市場 ( 9% ) よりも速いペースで成長すると予測されています。
高い収益成長: ALECの収益 ( 31.3% ) 20%よりも速いペースで成長すると予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: ALEC 3 年以内に赤字になると予測されています。